Keyphrases
Diabetic Macular Edema
100%
Thickness Reduction
100%
Anti-vascular Endothelial Growth Factor Therapy
100%
Best-corrected Visual Acuity
37%
Macular Volume
25%
Healthy Individuals
12%
Between-group
12%
Optical Coherence Tomography
12%
Fluorescein Angiography
12%
Control Subjects
12%
Non-diabetic
12%
Bevacizumab
12%
Intravitreal Injection
12%
Group Control
12%
Visual Acuity Improvement
12%
Ranibizumab
12%
Functional Parameters
12%
Macular Edema
12%
Medicine and Dentistry
Diabetic Macular Edema
100%
Vasculotropin
100%
Best Corrected Visual Acuity
37%
Diabetes Mellitus
12%
Macular Edema
12%
Fluorescein Angiography
12%
Optical Coherence Tomography
12%
Bevacizumab
12%
Intravitreal Administration
12%
Ranibizumab
12%
Nursing and Health Professions
Diabetic Macular Edema
100%
Vasculotropin
100%
Best Corrected Visual Acuity
37%
Diabetes Mellitus
12%
Intravitreal Drug Administration
12%
Bevacizumab
12%
Optical Coherence Tomography
12%
Fluorescence Angiography
12%
Macular Edema
12%
Ranibizumab
12%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Diabetic Macular Edema
100%
Diabetes Mellitus
12%
Intravitreal Administration
12%
Fluorescein
12%
Bevacizumab
12%
Macular Edema
12%
Ranibizumab
12%
Neuroscience
Vascular Endothelial Growth Factor
100%
Diabetes Mellitus
33%
Fluorescein
33%
Bevacizumab
33%
Ranibizumab
33%
Optics
33%
Veterinary Science and Veterinary Medicine
Vascular Endothelial Growth Factor
100%
Angiography
33%